APT Pharmaceuticals Incorporated
Registration country:United States
A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations.
APT Pharmaceuticals' initial focus is on the pulmonary delivery of treatments to address unmet need for serious lung diseases. The company is focused on the development of cyclosporine inhalation solution (CIS) for the prevention and treatment of chronic rejection in lung transplantation.